Clinical Trial Sheds Light on Daily CBD Use and Liver Enzymes

Everyday CBD Use Brings Risk to Liver

As cannabidiol (CBD) products become a fixture in American homes, a new FDA study has found that even low doses may quietly harm the liver in some users. Researchers conducted a placebo-controlled study with 201 healthy adults, giving some participants a common consumer dose of CBD for four weeks. While...

Even low doses of CBD may cause harm to the liver, FDA study finds

From capsules, gummies and other edibles, to oils and lotions, CBD products have become increasingly popular in the United States.

Clinical Trial Sheds Light on Daily CBD Use and Liver Enzymes

(MedPage Today) -- Daily use of cannabidiol (CBD) at doses commonly reported by consumers was associated with potentially dangerous increases in liver enzymes, a randomized clinical trial found. Among 201 healthy adult participants followed for...